A. Karakaş Et Al. , "Does obesity affect treatment response to secukinumab and its survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry.," Modern rheumatology , vol.34, pp.584-591, 2024
Karakaş, A. Et Al. 2024. Does obesity affect treatment response to secukinumab and its survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry.. Modern rheumatology , vol.34 , 584-591.
Karakaş, A., Gulle, S., Can, G., Dalkılıc, E., Akar, S., Koca, S. S., ... Pehlivan, Y.(2024). Does obesity affect treatment response to secukinumab and its survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry.. Modern rheumatology , vol.34, 584-591.
Karakaş, Ali Et Al. "Does obesity affect treatment response to secukinumab and its survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry.," Modern rheumatology , vol.34, 584-591, 2024
Karakaş, Ali Et Al. "Does obesity affect treatment response to secukinumab and its survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry.." Modern rheumatology , vol.34, pp.584-591, 2024
Karakaş, A. Et Al. (2024) . "Does obesity affect treatment response to secukinumab and its survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry.." Modern rheumatology , vol.34, pp.584-591.
@article{article, author={Ali Karakaş Et Al. }, title={Does obesity affect treatment response to secukinumab and its survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry.}, journal={Modern rheumatology}, year=2024, pages={584-591} }